menu
    • menu

    Company profile for Novellus

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Novellus is a biotechnology company working to develop engineered cellular medicines. We use our non-immunogenic mRNA molecules to reprogram and gene-edit cells safely, and with high efficiency. Novellus is headquartered in Cambridge, Massachusetts.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NovellusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1035 Cambridge Street Suite #17B Cambridge, MA 02141
    Telephone
    Telephone
    617.285.2632
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://novellus-inc.com/about/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novellus gets new name, new CEO as it completes pivot
    Novellus gets new name, new CEO as it completes pivot

    22 Feb 2021

    // Amirah Al Idrus FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/novellus-becomes-fore-bio-as-it-completes-pivot-from-diagnostics-to-precision-oncology

    Amirah Al Idrus FIERCEBIOTECH
    22 Feb 2021
    Share Share
    Novellus and Tempus Announce Collaboration to Accelerate Clinical Trial
    Novellus and Tempus Announce Collaboration to Accelerate Clinical Trial

    23 Nov 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201123005998/en

    BUSINESSWIRE
    23 Nov 2020
    Share Share
    Novellus Therapeutics Licenses Induced Mesenchymal Stem Cells (iMSCs)
    Novellus Therapeutics Licenses Induced Mesenchymal Stem Cells (iMSCs)

    13 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-receipt-of-5-million-milestone-and-material-payments-from-sanofi-301150958.html

    PRNEWSWIRE
    13 Oct 2020
    Share Share
    Novellus Closes $57M Series C Financing
    Novellus Closes $57M Series C Financing

    21 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200921005290/en/Novellus-Closes-57M-Series-C-Financing

    BUSINESSWIRE
    21 Sep 2020
    Share Share
    Daiichi's biotech unit Plexxikon signs away BRAF cancer drug
    Daiichi's biotech unit Plexxikon signs away BRAF cancer drug

    03 Jun 2020

    // Ben Adams FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/daiichi-s-biotech-unit-plexxikon-snaps-up-braf-cancer-drug-from-novellus

    Ben Adams FIERCE BIOTECH
    03 Jun 2020
    Share Share
    Novellus Executes Exclusive Worldwide License Agreement Plexxikon for PLX8394
    Novellus Executes Exclusive Worldwide License Agreement Plexxikon for PLX8394

    03 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200603005355/en

    BUSINESSWIRE
    03 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search